![]() |
|
Anticancer potency of Egyptian venom snakes on MCF-7 and HepG2 carcinoma cells
Sherif Abdallah, Khaled Y. Abdel-Halim, Abeer Alm-Eldeen
Environ Anal Health Toxicol. 2024;39(1):e2024001 Published online 2024 Jan 10 DOI: https://doi.org/10.5620/eaht.2024001
|
|
Citations to this article as recorded by
Therapeutic potentials of Cerastes cerastes venom: A comprehensive review of bioactive molecules and biomedical applications
Abderrezak Khelfi
Toxicon.2026; 274: 109023. CrossRef Venom-Derived Enzyme Inhibitors as Anticancer Agents: Structure–Activity Relationships, Molecular Targets and Mechanistic Insights
Ayorinde Victor Ogundele, Geetmani Singh Nongthombam, Adanna D. Nwagu, Héctor Hernán Silva, Oluwatoyin Adenike Fabiyi
Molecules.2026; 31(13): 2398. CrossRef Venom‐Derived Peptides in Breast Cancer: Pharmacological Mechanisms and Medicinal Chemistry‐Guided Translational Development
Radwa A. Amen, Alyaa Farid, Mohamed A. Abdel‐Rahman, Ahmed A. El‐Sherif, Yaser M. Hassan, Nadia R. Shehata, Rana H. Ahmed, Wael M. El‐Sayed
Archiv der Pharmazie.2026;[Epub] CrossRef Anticancer Activity of Snake Venom Against Breast Cancer: A Scoping Review
Eun-Jin Kim, Jang-Kyung Park, Soo-Hyun Sung, Hyun-Kyung Sung
Toxins.2025; 17(10): 477. CrossRef RETRACTED: Vp1 protein peptide molecule and LAAO in liver cancer gene therapy: VN-NsLAAO fusion protein regulates mir-149-RAS liver cancer cell proliferation pathway
Jingshun Meng, Yun He, Yinsa Xu, Zhankui Wang, Haoyue Zhong
International Journal of Biological Macromolecules.2025; 317: 144819. CrossRef Snake venom-derived peptides as anticancer candidates: Pioneering next-generation therapies
José R. Almeida, Edgar A. Pinos-Tamayo, Bruno Mendes, Alberto A. Robles-Loaiza, Rony Abdi Syahputra, Ana Gabriela Silva Oliveira, Rosy Iara Maciel de A. Ribeiro
Biochimica et Biophysica Acta (BBA) - Reviews on C.2025; 1880(6): 189479. CrossRef
|